Symbols / SRXH $0.14 +4.81% SRx Health Solutions Inc.
SRXH Chart
About
SRx Health Solutions Inc., through its subsidiaries, engages in the specialty pharmacy and pet health and wellness businesses in the United States, Taiwan, and internationally. The company offers pet health and wellness products in multiple forms, including kibble, canned food, freeze-dried raw food, treats, and supplements. The company also offers consumer products, including dry food, wet food, treats, and other premium pet products. The company also offers pharmacy services, patient support programs, diagnostic services, and clinical trials. The company was founded in 2013 and is headquartered in North Palm Beach, Florida.
Fundamentals
Scroll to Statements| Sector | Consumer Defensive | Industry | Packaged Foods | Market Cap | 51.52M |
| Enterprise Value | 62.85M | Income | -17.25M | Sales | 9.34M |
| Book/sh | -0.11 | Cash/sh | 0.04 | Dividend Yield | — |
| Payout | 0.00% | Employees | 10 | IPO | — |
| P/E | — | Forward P/E | — | PEG | — |
| P/S | 5.52 | P/B | -1.36 | P/C | — |
| EV/EBITDA | -4.92 | EV/Sales | 6.73 | Quick Ratio | 0.69 |
| Current Ratio | 0.80 | Debt/Eq | 596.71 | LT Debt/Eq | — |
| EPS (ttm) | -0.17 | EPS next Y | — | EPS Growth | — |
| Revenue Growth | — | Earnings | — | ROA | — |
| ROE | — | ROIC | — | Gross Margin | 27.62% |
| Oper. Margin | -135.02% | Profit Margin | 0.00% | Shs Outstand | 358.26M |
| Shs Float | 277.46M | Short Float | 2.19% | Short Ratio | 0.28 |
| Short Interest | — | 52W High | 2.02 | 52W Low | 0.08 |
| Beta | — | Avg Volume | 28.05M | Volume | 25.54M |
| Target Price | — | Recom | None | Prev Close | $0.14 |
| Price | $0.14 | Change | 4.81% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$0.15
Latest analyst target
3. DCF / Fair value
—
Simplified FCF or EPS-based estimate
Ratings
Current target
$0.15
Low
—
High
—
Mean
—
- S&P fell 4.98%; SRx Health says EMJX AI hedge pool gained 5.69% - Stock Titan ue, 07 Apr 2026 13
- SRXH Stock Price, Quote & Chart | SRX HEALTH SOLUTIONS INC (NYSEARCA:SRXH) - chartmill.com hu, 02 Apr 2026 07
- SRXH Stock Climbed 15% Today — What’s Driving The Rally? - stocktwits.com hu, 05 Mar 2026 08
- SRx Health (SRXH) CEO discloses common, preferred and warrant stakes - Stock Titan Fri, 03 Apr 2026 15
- SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine - chartmill.com ue, 07 Apr 2026 13
- SRXH Stock Rises Premarket: Incoming CEO Eric Jackson Says ‘No Decision’ Yet On Reverse Split - stocktwits.com Mon, 19 Jan 2026 08
- SRx Health (SRXH) CEO reports new equity, warrant and preferred awards - Stock Titan Fri, 03 Apr 2026 15
- SRXH Stock Pulls Back After Slashing Bitcoin, Ethereum Shorts To ‘Nearly Zero’ In Eric Jackson’s $18M Crypto Pivot - stocktwits.com ue, 03 Feb 2026 08
- Gold enters the mix as SRx Health reshapes DeFi, EM hedges - Stock Titan Wed, 25 Mar 2026 07
- This new trading tool logs every market regime shift to an immutable ledger - Stock Titan Mon, 09 Mar 2026 07
- SRx Health cancels 125M potential shares in balance-sheet reset - Stock Titan Wed, 11 Feb 2026 08
- [8-K] SRx Health Solutions, Inc. Reports Material Event | SRXH 8-K Filing - Stock Titan Wed, 18 Mar 2026 07
- Healthcare firm slashes Bitcoin, Ethereum short bets in volatile market - Stock Titan ue, 03 Feb 2026 08
- Pet wellness brand SRx Health shifts $18M into Bitcoin and Ethereum - Stock Titan Fri, 13 Feb 2026 08
- Stock exchange warns SRx Health over 7.5M new share issuance - Stock Titan Fri, 20 Feb 2026 08
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-09-30 | 2024-09-30 |
|---|---|---|---|
| Total Revenue |
|
6.53
|
0.00
|
| Operating Revenue |
|
6.53
|
0.00
|
| Cost Of Revenue |
|
5.01
|
0.00
|
| Reconciled Cost Of Revenue |
|
5.01
|
0.00
|
| Gross Profit |
|
1.53
|
0.00
|
| Operating Expense |
|
12.93
|
0.00
|
| Selling General And Administration |
|
12.93
|
0.00
|
| Total Expenses |
|
17.94
|
0.00
|
| Operating Income |
|
-11.41
|
0.00
|
| Total Operating Income As Reported |
|
-11.41
|
0.00
|
| EBITDA |
|
-7.98
-281.90%
|
4.39
|
| Normalized EBITDA |
|
-11.38
-359.29%
|
4.39
|
| Reconciled Depreciation |
|
0.03
-99.29%
|
4.39
|
| EBIT |
|
-8.01
|
0.00
|
| Total Unusual Items |
|
3.40
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
3.40
|
0.00
|
| Special Income Charges |
|
3.40
|
0.00
|
| Other Special Charges |
|
0.72
|
—
|
| Restructuring And Mergern Acquisition |
|
-4.11
|
0.00
|
| Net Income |
|
-45.01
-4.53%
|
-43.05
|
| Pretax Income |
|
-8.64
|
0.00
|
| Net Non Operating Interest Income Expense |
|
-0.63
|
0.00
|
| Interest Expense Non Operating |
|
0.63
|
0.00
|
| Net Interest Income |
|
-0.63
|
0.00
|
| Interest Expense |
|
0.63
|
0.00
|
| Other Income Expense |
|
3.40
|
—
|
| Tax Provision |
|
0.00
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-45.01
-4.53%
|
-43.05
|
| Net Income From Continuing Operation Net Minority Interest |
|
-8.64
|
0.00
|
| Net Income From Continuing And Discontinued Operation |
|
-45.01
-4.53%
|
-43.05
|
| Net Income Continuous Operations |
|
-8.64
|
0.00
|
| Net Income Discontinuous Operations |
|
-36.37
+15.53%
|
-43.05
|
| Normalized Income |
|
-12.03
|
0.00
|
| Net Income Common Stockholders |
|
-45.01
-4.53%
|
-43.05
|
| Diluted EPS |
|
-2.13
+29.25%
|
-3.01
|
| Basic EPS |
|
-2.13
+29.25%
|
-3.01
|
| Basic Average Shares |
|
21.11
+47.59%
|
14.30
|
| Diluted Average Shares |
|
21.11
+47.59%
|
14.30
|
| Diluted NI Availto Com Stockholders |
|
-45.01
-4.53%
|
-43.05
|
| Line Item | Trend | 2025-09-30 | 2024-09-30 |
|---|---|---|---|
| Total Assets |
|
8.40
-75.12%
|
33.76
|
| Current Assets |
|
8.13
-40.41%
|
13.64
|
| Cash Cash Equivalents And Short Term Investments |
|
1.31
+1134.91%
|
0.11
|
| Cash And Cash Equivalents |
|
1.31
+1134.91%
|
0.11
|
| Receivables |
|
3.94
-59.18%
|
9.66
|
| Accounts Receivable |
|
3.94
-57.47%
|
9.28
|
| Other Receivables |
|
—
|
0.02
|
| Inventory |
|
2.08
-38.32%
|
3.37
|
| Raw Materials |
|
0.54
|
0.00
|
| Finished Goods |
|
1.54
-54.41%
|
3.37
|
| Other Current Assets |
|
0.79
+60.08%
|
0.50
|
| Total Non Current Assets |
|
0.28
-98.63%
|
20.13
|
| Net PPE |
|
0.11
-99.14%
|
12.52
|
| Gross PPE |
|
0.56
-96.84%
|
17.70
|
| Accumulated Depreciation |
|
-0.45
+91.27%
|
-5.18
|
| Properties |
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.00
-100.00%
|
2.29
|
| Machinery Furniture Equipment |
|
0.42
-44.31%
|
0.75
|
| Other Properties |
|
0.14
-98.49%
|
9.51
|
| Leases |
|
0.00
-100.00%
|
5.15
|
| Goodwill And Other Intangible Assets |
|
0.00
-100.00%
|
7.00
|
| Other Intangible Assets |
|
—
|
7.00
|
| Non Current Accounts Receivable |
|
—
|
0.46
|
| Non Current Deferred Assets |
|
0.00
-100.00%
|
0.15
|
| Non Current Deferred Taxes Assets |
|
0.00
-100.00%
|
0.15
|
| Other Non Current Assets |
|
0.17
|
—
|
| Total Liabilities Net Minority Interest |
|
8.00
-91.01%
|
88.88
|
| Current Liabilities |
|
3.54
-95.64%
|
81.30
|
| Payables And Accrued Expenses |
|
3.52
-91.67%
|
42.28
|
| Payables |
|
2.15
-94.69%
|
40.43
|
| Accounts Payable |
|
2.15
-94.61%
|
39.84
|
| Current Accrued Expenses |
|
1.38
-25.88%
|
1.85
|
| Total Tax Payable |
|
0.00
-100.00%
|
0.30
|
| Income Tax Payable |
|
0.00
-100.00%
|
0.30
|
| Current Debt And Capital Lease Obligation |
|
0.02
-99.95%
|
38.99
|
| Current Debt |
|
—
|
37.52
|
| Other Current Borrowings |
|
—
|
33.80
|
| Current Capital Lease Obligation |
|
0.02
-98.57%
|
1.47
|
| Current Deferred Liabilities |
|
0.00
-100.00%
|
0.03
|
| Current Deferred Revenue |
|
0.00
-100.00%
|
0.03
|
| Total Non Current Liabilities Net Minority Interest |
|
4.45
-41.27%
|
7.58
|
| Long Term Debt And Capital Lease Obligation |
|
4.45
-29.55%
|
6.32
|
| Long Term Debt |
|
4.45
+539.66%
|
0.70
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
5.62
|
| Non Current Deferred Liabilities |
|
0.00
-100.00%
|
1.26
|
| Non Current Deferred Taxes Liabilities |
|
0.00
-100.00%
|
1.26
|
| Stockholders Equity |
|
0.41
+100.74%
|
-55.12
|
| Common Stock Equity |
|
0.41
+100.74%
|
-55.12
|
| Capital Stock |
|
0.03
+40.91%
|
0.02
|
| Common Stock |
|
0.03
+40.91%
|
0.02
|
| Share Issued |
|
24.92
+74.22%
|
14.30
|
| Ordinary Shares Number |
|
24.92
+74.22%
|
14.30
|
| Additional Paid In Capital |
|
23.30
+86.57%
|
12.49
|
| Retained Earnings |
|
-22.93
+67.26%
|
-70.03
|
| Gains Losses Not Affecting Retained Earnings |
|
0.00
-100.00%
|
2.40
|
| Other Equity Adjustments |
|
—
|
2.40
|
| Total Equity Gross Minority Interest |
|
0.41
+100.74%
|
-55.12
|
| Total Capitalization |
|
4.86
+108.93%
|
-54.42
|
| Working Capital |
|
4.58
+106.77%
|
-67.67
|
| Invested Capital |
|
4.86
+128.75%
|
-16.90
|
| Total Debt |
|
4.47
-90.13%
|
45.31
|
| Net Debt |
|
3.14
-91.75%
|
38.11
|
| Capital Lease Obligations |
|
0.02
-99.70%
|
7.09
|
| Net Tangible Assets |
|
0.41
+100.66%
|
-62.12
|
| Tangible Book Value |
|
0.41
+100.66%
|
-62.12
|
| Duefrom Related Parties Current |
|
0.00
-100.00%
|
0.37
|
| Dueto Related Parties Current |
|
0.00
-100.00%
|
0.29
|
| Line Of Credit |
|
0.00
-100.00%
|
3.71
|
| Line Item | Trend | 2025-09-30 | 2024-09-30 |
|---|---|---|---|
| Operating Cash Flow |
|
-8.14
-450.95%
|
-1.48
|
| Cash Flow From Continuing Operating Activities |
|
-8.14
-450.95%
|
-1.48
|
| Net Income From Continuing Operations |
|
-8.64
+79.93%
|
-43.05
|
| Depreciation Amortization Depletion |
|
0.03
-99.29%
|
4.39
|
| Depreciation And Amortization |
|
0.03
-99.29%
|
4.39
|
| Other Non Cash Items |
|
-3.11
-769.83%
|
0.46
|
| Stock Based Compensation |
|
3.21
-12.57%
|
3.67
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
21.25
|
| Deferred Tax |
|
0.00
+100.00%
|
-1.12
|
| Deferred Income Tax |
|
0.00
+100.00%
|
-1.12
|
| Operating Gains Losses |
|
0.04
|
—
|
| Gain Loss On Sale Of PPE |
|
0.04
|
0.00
|
| Change In Working Capital |
|
0.33
-97.43%
|
12.93
|
| Change In Receivables |
|
5.41
+1421.76%
|
-0.41
|
| Changes In Account Receivables |
|
5.41
+1421.76%
|
-0.41
|
| Change In Inventory |
|
0.50
-80.60%
|
2.56
|
| Change In Prepaid Assets |
|
-0.83
-300.24%
|
0.41
|
| Change In Payables And Accrued Expense |
|
-4.74
-145.75%
|
10.36
|
| Change In Accrued Expense |
|
1.25
+13800.00%
|
0.01
|
| Change In Payable |
|
-5.99
-157.87%
|
10.35
|
| Change In Account Payable |
|
-5.99
-157.87%
|
10.35
|
| Investing Cash Flow |
|
5.91
+641.74%
|
-1.09
|
| Cash Flow From Continuing Investing Activities |
|
5.91
+641.74%
|
-1.09
|
| Net PPE Purchase And Sale |
|
0.00
-100.00%
|
1.25
|
| Sale Of PPE |
|
0.00
-100.00%
|
1.25
|
| Capital Expenditure |
|
-2.08
|
—
|
| Net Business Purchase And Sale |
|
5.94
+354.39%
|
-2.33
|
| Purchase Of Business |
|
0.00
+100.00%
|
-2.33
|
| Net Intangibles Purchase And Sale |
|
-2.08
|
0.00
|
| Purchase Of Intangibles |
|
-2.08
|
0.00
|
| Net Other Investing Changes |
|
2.04
|
—
|
| Financing Cash Flow |
|
12.17
+1205.90%
|
0.93
|
| Cash Flow From Continuing Financing Activities |
|
12.17
+1205.90%
|
0.93
|
| Net Issuance Payments Of Debt |
|
3.66
+442.52%
|
0.68
|
| Issuance Of Debt |
|
7.78
+14.72%
|
6.78
|
| Repayment Of Debt |
|
-4.12
+32.57%
|
-6.11
|
| Long Term Debt Issuance |
|
6.12
+45.02%
|
4.22
|
| Long Term Debt Payments |
|
-1.66
+72.90%
|
-6.11
|
| Net Long Term Debt Issuance |
|
4.46
+336.74%
|
-1.89
|
| Short Term Debt Issuance |
|
1.66
-35.22%
|
2.56
|
| Short Term Debt Payments |
|
-2.46
|
0.00
|
| Net Short Term Debt Issuance |
|
-0.80
-131.35%
|
2.56
|
| Net Common Stock Issuance |
|
-0.14
-114.91%
|
0.92
|
| Common Stock Payments |
|
-0.14
|
0.00
|
| Repurchase Of Capital Stock |
|
-0.14
|
0.00
|
| Net Other Financing Charges |
|
8.65
+1406.04%
|
-0.66
|
| Changes In Cash |
|
9.93
+707.15%
|
-1.64
|
| Effect Of Exchange Rate Changes |
|
-0.21
+39.30%
|
-0.34
|
| Beginning Cash Position |
|
0.11
-94.91%
|
2.08
|
| End Cash Position |
|
1.31
+1134.91%
|
0.11
|
| Free Cash Flow |
|
-10.22
-591.41%
|
-1.48
|
| Interest Paid Supplemental Data |
|
0.33
-87.64%
|
2.66
|
| Common Stock Issuance |
|
0.00
-100.00%
|
0.92
|
| Issuance Of Capital Stock |
|
0.00
-100.00%
|
0.92
|
| Other Cash Adjustment Outside Changein Cash |
|
-8.52
|
0.00
|
| Sale Of Business |
|
5.94
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 42026-04-03 View
- 42026-04-03 View
- 8-K2026-03-18 View
- 8-K2026-03-03 View
- 8-K2026-02-20 View
- 10-Q2026-02-13 View
- 8-K2026-02-12 View
- 8-K2026-01-08 View
- 8-K2025-12-23 View
- 8-K2025-12-16 View
- 10-K2025-12-05 View
- 8-K2025-11-20 View
- 8-K2025-11-10 View
- 8-K2025-10-31 View
- 8-K2025-10-17 View
- 8-K2025-10-09 View
- 42025-10-07 View
- 8-K2025-10-06 View
- 10-Q2025-09-30 View
- 8-K2025-09-19 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|